What's Going On With Bristol Myers Squibb Stock Friday?
I'm PortAI, I can summarize articles.
Bristol Myers Squibb & Co. ( NYSE:BMY ) on Friday agreed to acquire Orbital Therapeutics, a privately held biotechnology company focused on RNA medicines that reprogram the immune system in vivo. The US drug giant agreed to pay $1.5 billion in cash.
Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments